Enveda | Premji Invest

Back to full portfolio

AI driven drug discovery platform focused on novel therapeutics from plant chemistry.

"Premji Invest is an exciting new partner for Enveda. Their belief in our vision and support in our Series B2 financing accelerates our platform and helps advance multiple clinical candidates. Their evergreen capital structure, combined with their expertise and strategic guidance, is invaluable as we push forward to develop a lasting, technology-driven biopharma company."

Viswa Colluru, CEO & Founder

Viswa Colluru, CEO & Founder

Founder(s)

Viswa Colluru

THEME(S)

Emerging therapeutic platforms

SECTOR(S)

Healthcare

Investment Stage

Early

Company Status

Private

Enveda in Global Health

Enveda Translates Life's Chemistry into Medicines

Perspectives

More about Enveda

Enveda | Efficient drug development, naturally

November 26, 2024

Enveda | Efficient drug development, naturally

Enveda Announces First Candidate Discovered From Nature Using AI Advances to Clinical Trials

November 13, 2024

Enveda Announces First Candidate Discovered From Nature Using AI Advances to Clinical Trials

Breaking Barriers: Simultaneous Target and Drug Discovery at Scale

January 30, 2025

Breaking Barriers: Simultaneous Target and Drug Discovery at Scale

Enveda raises $55M to combine ancient remedies with AI for drug discovery

Enveda raises $55M to combine ancient remedies with AI for drug discovery